HLA I类与II类基因在系统性硬化症相关间质性肺病发病中的新见解
该研究纳入2412例SSc-ILD⁺患者、3550例SSc-ILD⁻患者和15076名欧洲血统对照,开展迄今最大规模MHC区域关联研究。条件分析检出12个位于HLA I类和II类基因内的显著关联;调整抗拓扑异构酶抗体(ATA)后II类信号减弱而I类信号不受影响。整合遗传、临床和人口学变量的复合评分预测SSc-ILD的AUC为0.754,显著优于任何单一变量模型。
要点
- HLA I类和II类基因共12个位点与SSc-ILD显著关联。
- ATA调整削弱II类HLA信号,I类HLA关联保持稳定。
- 复合评分预测SSc-ILD的AUC为0.754,优于单变量模型。
核心结论
- SSc-ILD存在HLA I类和II类基因关联,支持CD8+ T细胞和ATA参与发病。
- 整合遗传信息的复合评分可提升SSc-ILD高危患者识别效能。
研究设计与样本
- 基于10个国际队列的MHC区域关联研究,纳入2412例SSc-ILD⁺、3550例SSc-ILD⁻和15076名欧洲血统对照。
- 对MHC区域进行插补后行逆方差加权荟萃分析,并做条件逐步分析、ATA状态调整及显著SNP功能注释。
- 构建整合遗传、临床和人口学变量的复合评分用于预测SSc-ILD。
主要发现
- 条件分析后检出12个位于HLA I类和II类基因内的显著关联。
- 调整ATA后II类HLA变异的显著性降低,而I类HLA变异未受影响。
- 复合评分预测SSc-ILD的AUC为0.754,显著优于任何单一变量模型。
临床怎么用
- 对SSc患者可关注HLA I类基因背景,其关联不受ATA状态影响。
- 遗传信息联合临床与人口学变量有助于识别SSc-ILD高危患者。
局限性
- 研究人群限于欧洲血统,结论外推至其他人群需谨慎。
- 复合评分的预测效能为AUC 0.754,尚需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Systemic sclerosis-associated interstitial lung disease (SSc-ILD) is the leading cause of mortality in systemic sclerosis (SSc), yet its genetic architecture remains incompletely understood. Therefore, given the key role of the major histocompatibility complex (MHC) in SSc, we aimed to perform a comprehensive MHC-wide association study in the largest SSc-ILD cohort to date. METHODS: We analysed 2412 patients with SSc-ILD⁺, 3550 patients with SSc-ILD⁻, and 15,076 controls of European ancestry from 10 international cohorts. After quality control, the MHC region was imputed, and inverse variance weighted meta-analysis was performed. Subsequently, conditional stepwise analyses, adjustment for antitopoisomerase autoantibody (ATA) status, and functional annotation of significant single-nucleotide polymorphisms were performed. Finally, we constructed a composite score combining genetic, clinical, and demographic variables to predict SSc-ILD. RESULTS: After conditional analysis, we detected 12 significant associations within class I and class II human leukocyte antigen (HLA) genes. ATA adjustment reduced the significance of class II HLA variants, whereas class I HLA variants remained unaffected. Finally, the built composite score had an area under the curve of 0.754, significantly outperforming the models including any of the variables alone. CONCLUSIONS: In this study, we identify genetic mechanisms underlying SSc-ILD that support the potential implication of CD8+ T cells and ATAs in its pathogenesis. Moreover, we also demonstrate the enhanced efficacy of integrating genetic information into predictive models to detect patients at high risk of SSc-ILD. These findings provide new insights into disease pathogenesis and suggest potential biomarkers and therapeutic targets for improved patient management.
引用
- Rosa-Baez C, Rangel-Peláez C, Rodriguez-Martin I, et al. Novel HLA class I and II insights into the pathogenesis of systemic sclerosis-associated interstitial lung disease. Ann Rheum Dis. 2026. PMID: 42218078. doi:10.1016/j.ard.2026.05.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。